# US 2025/0368701 A1 · Coiled-coil peptides for force-dependent applications

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0368701 A1
- Document ID: US20250368701A1
- Status: Published application
- Kind: A1
- Application number: 18/874,732
- Filed: 2023-06-30
- Published: 2025-12-04
- Earliest claimed: 2022-06-30
- Assignees: Yale University
- Applicants: Yale University
- Inventors: Julien Berro; Yuan Ren; Yongli Zhang
- Web page: https://patentgrep.com/patent/US20250368701A1

## CPC

- C07K 14/001: {by chemical synthesis}
- C07K 14/47: from mammals
- A61K 38/17: from animals; from humans {(enzyme inhibitors A61K38/005)}
- G01N 33/68: involving proteins, peptides or amino acids {(involving lipoproteins G01N33/92)}
- C07K 2319/00: Fusion polypeptide
- C07K 2319/01: containing a localisation/targetting motif
- C07K 2319/60: containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Force-sensing peptides that can be used as sensor molecules or can be used for signal transduction by detecting a force and translating the force into a biological signal are described as well as methods of using the force-sensing peptides.

## Claims

### Claim 1

A force sensing peptide comprising two α-helix domains linked by a linker sequence wherein the two α-helix domains form a coiled coil domain, referred to as a closed conformation, in the absence of external force, and further wherein the coiled coil domain undergoes a conformational change to an open conformation in the presence of a force above an uncoiling threshold level for the coiled coil domain.

### Claim 2 (depends on 1)

The force sensing peptide of claim 1, wherein the force sensing peptide is operably linked to a target molecule of interest, whereby the force sensing peptide undergoes the conformational change when force is applied to the target molecule of interest.

### Claim 3 (depends on 1)

The force sensing peptide of claim 1, wherein the linker sequence comprises at least one functional domain or moiety for generating a signal when the force sensing peptide is in an open conformation.

### Claim 4 (depends on 3)

The force sensing peptide of claim 3, wherein at least one functional domain or moiety is selected from the group consisting of a fluorescent protein or a fragment thereof, a circular fluorescent protein, a protein cleavage domain, an RNA binding molecule, a DNA-binding domain, an epitope for recognition by a binding molecule, an ion-binding domain, a lipid-binding domain, a peptide containing residues for post-translational modification, a peptide containing unnatural amino acids, a peptide that is a toxin to cells, a peptide with antibacterial activity, a peptide with anti-viral activity, a peptide with anti-fungal activity, a peptide with enzymatic activity, a peptide that modifies the enzymatic activity of other proteins, a peptide containing localization signal for cellular compartments, a peptide containing secretion signal, and a peptide that binds another peptide or protein construct.

### Claim 5 (depends on 1)

The force sensing peptide of claim 1, wherein the uncoiling threshold level for the coiled coil domain is at least 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, or more than 25 piconewtons (pN).

### Claim 6 (depends on 1)

The force sensing peptide of claim 1, wherein the peptide comprises at least one α-helix domain selected from the group consisting of SEQ ID NO:1-SEQ ID NO:40.

### Claim 7 (depends on 1)

The force sensing peptide of claim 1, wherein the peptide comprises at least one set of α-helix domains selected from the group consisting of:
a) SEQ ID NO:1 and SEQ ID NO:21;
b) SEQ ID NO:2 and SEQ ID NO:21;
c) SEQ ID NO:2 and SEQ ID NO:22;
d) SEQ ID NO:3 and SEQ ID NO:23;
e) SEQ ID NO:4 and SEQ ID NO:23;
f) SEQ ID NO:4 and SEQ ID NO:24;
g) SEQ ID NO:5 and SEQ ID NO:25;
h) SEQ ID NO:6 and SEQ ID NO:26;
i) SEQ ID NO:7 and SEQ ID NO:27;
j) SEQ ID NO:8 and SEQ ID NO:28;
k) SEQ ID NO:9 and SEQ ID NO:29;
l) SEQ ID NO:10 and SEQ ID NO:30;
m) SEQ ID NO:11 and SEQ ID NO:31;
n) SEQ ID NO:12 and SEQ ID NO:32;
o) SEQ ID NO:13 and SEQ ID NO:33;
p) SEQ ID NO:14 and SEQ ID NO:34;
q) SEQ ID NO:15 and SEQ ID NO:35;
r) SEQ ID NO:16 and SEQ ID NO:36;
s) SEQ ID NO:17 and SEQ ID NO:37;
t) SEQ ID NO:18 and SEQ ID NO:38;
u) SEQ ID NO:19 and SEQ ID NO:39; and
v) SEQ ID NO:20 and SEQ ID NO:40,
wherein the set of α-helix domains are linked by a linker sequence.

### Claim 8 (depends on 1)

The force sensing peptide of claim 1, wherein the peptide comprises at least one linker sequence selected from the group consisting of SEQ ID NO:41-SEQ ID NO:56.

### Claim 9 (depends on 1)

The force sensing peptide of claim 1, wherein the peptide comprises a sequence selected from the group consisting of SEQ ID NO:57-SEQ ID NO:80.

### Claim 10 (depends on 2)

The force sensing peptide of claim 2, wherein the target molecule of interest is selected from the group consisting of a detectable moiety, a fluorescent protein, a purification tag, a targeting domain, a cellular localization signal, a DNA molecule, an RNA molecule, cAMP, cGMP, eicosapentaenoic acid, eicosatetraenoic acid, a phosphatidylcholine, a phosphatidylinositol, a phosphatidylethanolamine, an aminomethyl polystyrene linker, a chloromethyl polystyrene linker, a PEG linker, a solid-phase protein synthesis resin, a C-terminal fragment of End4p, a C-terminal fragment of actin, a C-terminal fragment of clathrin, a C-terminal fragment of vinculin, a C-terminal fragment of talin, a C-terminal fragment of integrin, glycogen, cellulose, a therapeutic agent, an antibiotic, an antiviral, an anti-fungal, an anti-helminthic, an anti-inflammatory molecule, and a chemotherapeutic.

### Claim 11 (depends on 1)

A system for determination of the level of force exerted on a target of interest, the system comprising at least two force sensing peptides of claim 1, where the at least two force sensing peptides have different uncoiling threshold levels.

### Claim 12 (depends on 1)

A nucleic acid molecule encoding a force sensing peptide of claim 1.

### Claim 13 (depends on 12)

A genetically modified host cell comprising a nucleic acid molecule of claim 12.

### Claim 14 (depends on 1)

A method of detecting the force applied to a target molecule of interest, the method comprising contacting a target molecule of interest operably linked to a force sensing peptide of claim 1 with a sufficient level of force to induce a conformational change in the force sensing peptide, and detecting the presence of the open conformation of the force sensing peptide.

### Claim 15 (depends on 14)

The method of claim 14, wherein the force sensing peptide comprises a linker sequence comprising at least one functional domain or moiety for generating a signal when the force sensing peptide is in an open conformation.

### Claim 16 (depends on 15)

The method of claim 15, wherein at least one functional domain or moiety is selected from the group consisting of a fragment of a fluorescent protein, a bioluminescent protein, a circular fluorescent protein, a protein cleavage domain, an RNA binding molecule, a DNA-binding domain, an epitope for recognition by a binding molecule, an ion-binding domain, a lipid-binding domain, a peptide containing residues for post-translational modification, a peptide containing unnatural amino acids, a peptide that is a toxin to cells, a peptide with anti-bacterial activity, a peptide with anti-viral activity, a peptide with anti-fungal activity, a peptide with enzymatic activity, a peptide that modifies the enzymatic activity of other proteins, a peptide containing localization signal for cellular compartments, and a peptide containing secretion signal.

### Claim 17 (depends on 15)

The method of claim 15, wherein the method of detecting comprises detecting a fluorescent signal that is generated in the presence of the open conformation of the force sensing peptide.

### Claim 18 (depends on 15)

The method of claim 15, wherein the method of detecting comprises detecting a bioluminescent signal that is generated in the presence of the open conformation of the force sensing peptide.

### Claim 19 (depends on 15)

The method of claim 15, wherein the method of detecting comprises detecting a differential level of a protein or an mRNA molecule when the force sensing peptide is in the open conformation.

### Claim 20 (depends on 15)

The method of claim 15, wherein the method of detecting comprises detecting a change in localization of the target molecule due to cleavage of a peptide cleavage domain that is exposed when the force sensing peptide is in the open conformation.

### Claim 21 (depends on 14)

The method of claim 14, wherein the peptide comprises at least one α-helix domain selected from the group consisting of SEQ ID NO:1-SEQ ID NO:40.

### Claim 22 (depends on 14)

The method of claim 14, wherein the peptide comprises at least one set of α-helix domains selected from the group consisting of:
a) SEQ ID NO:1 and SEQ ID NO:21;
b) SEQ ID NO:2 and SEQ ID NO:21;
c) SEQ ID NO:2 and SEQ ID NO:22;
d) SEQ ID NO:3 and SEQ ID NO:23;
e) SEQ ID NO:4 and SEQ ID NO:23;
f) SEQ ID NO:4 and SEQ ID NO:24;
g) SEQ ID NO:5 and SEQ ID NO:25;
h) SEQ ID NO:6 and SEQ ID NO:26;
i) SEQ ID NO:7 and SEQ ID NO:27;
j) SEQ ID NO:8 and SEQ ID NO:28;
k) SEQ ID NO:9 and SEQ ID NO:29;
l) SEQ ID NO:10 and SEQ ID NO:30;
m) SEQ ID NO:11 and SEQ ID NO:31;
n) SEQ ID NO:12 and SEQ ID NO:32;
o) SEQ ID NO:13 and SEQ ID NO:33;
p) SEQ ID NO:14 and SEQ ID NO:34;
q) SEQ ID NO:15 and SEQ ID NO:35;
r) SEQ ID NO:16 and SEQ ID NO:36;
s) SEQ ID NO:17 and SEQ ID NO:37;
t) SEQ ID NO:18 and SEQ ID NO:38;
u) SEQ ID NO:19 and SEQ ID NO:39; and
v) SEQ ID NO:20 and SEQ ID NO:40,
wherein the set of α-helix domains are linked by a linker sequence.

### Claim 23 (depends on 14)

The method of claim 14, wherein the peptide comprises at least one linker sequence selected from the group consisting of SEQ ID NO:41-SEQ ID NO:56.

### Claim 24 (depends on 14)

The method of claim 14, wherein the peptide comprises at least one sequence selected from the group consisting of SEQ ID NO:57-SEQ ID NO:80.
